Ascension ups Nick Ragone to EVP, chief marketing and comms officer
The promotion is part of reshuffling of the healthcare company’s leadership.
News
3 campaigns that wowed industry leaders
Here are three of the campaigns most frequently mentioned by agency CEOs, directors and presidents. In other words, the work the industry’s leaders are talking about.
In pictures: MM&M’s 2019 Hall of Femme
Take a look at some of the highlights from this year’s Hall of Femme event in New York City.
Five things for pharma marketers to know: Tuesday, June 11, 2019
Measles outbreak hits two more states; The near death and new life of Outcome Health; Roche lymphoma combo treatment gets accelerated FDA approval.
The near death and new life of Outcome Health
When allegations of widespread fraud rocked Outcome and its clients 18 months ago, the industry started writing the company’s obituary. But new, more rigorous auditing procedures and a devotion to repairing strained relationships have combined to make Outcome the year’s most fascinating redemption story.
W2O: Healthcare companies need more than reputation, they need relevance
W2O released a version of its Relevance Index just for healthcare companies.
Soundbites from Hall of Femme: What role can men play in empowering women?
Hall of Femme honorees Kamala Prince and Kirsty Whelan and Women to Watch honoree Miranda Madar share how men can play a role in empowering women.
Five things for pharma marketers to know: Monday, June 10, 2019
Sanofi appoints next CEO; E-cigarette makers warned for using social media influencers; Cannabis use among seniors increases tenfold.
Pfizer takes to Twitter to refute ‘Washington Post’ story
The drugmaker said that its decision not to pursue clinical trials on Alzheimer’s for Enbrel was based on science, not financial predictions.
Sanofi names former Novartis executive as CEO
Paul Hudson will replace the retiring Olivier Brandicourt in September.
Want to read more?
Please login or register first to view this content.
